【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Molecule Type
08. Geographical Segmentation
09. Buying Criteria
10. Global Protein Therapeutics Market
10.1 Introduction
10.2 Drivers, Challenges and Trends
10.3 Market Size and Forecast
10.4 Market Segmentation by Molecule Type
10.4.1 Global Monoclonal Antibodies Market
10.4.2 Global Enzymes Market
10.4.3 Global Other Protein Therapeutics Market
11. Global Vaccines Market
11.1 Introduction
11.2 Drivers, Challenges and Trends
11.3 Market Size and Forecast
11.4 Market Segmentation by Composition
11.5 Market Segmentation by End-user Age Group
11.5.1 Global Pediatric Vaccines Market
11.5.2 Global Adult Vaccines Market
12. Global Cell Therapy Market
12.1 Introduction
12.2 Drivers, Challenges and Trends
12.3 Market Size and Forecast
13. Market Growth Drivers
13.1.1 Overall Market Drivers
13.1.2 Segment Specific Drivers
14. Drivers and their Impact
15. Market Challenges
15.1.1 Overall Market Challenges
15.1.2 Segment Specific Challenges
16. Impact of Drivers and Challenges
17. Market Trends
17.1.1 Overall Market Trends
17.1.2 Segment Specific Trends
18. Trends and their Impact
19. Competitive Scenario
19.1 Key News
19.2 Mergers and Acquisitions
20. Market Share Analysis 2013
20.1 Market Snapshot of Top Vendors
20.2 Market Share of Key Vendors
20.3 Market Forecast of Key Vendors
20.3.1 F. Hoffmann-La Roche
20.3.2 Sanofi
20.3.3 Amgen
20.3.4 Novo Nordisk
21. Market Assessment of Major Biologic Therapeutics of Key Vendors
21.1 F. Hoffmann-La Roche
21.1.1 Avastin
21.1.2 Herceptin
21.1.3 Kadcyla
21.1.4 Lucentis
21.1.5 MabThera/Rituxan
21.1.6 Pegasys
21.1.7 Perjeta
21.2 Sanofi
21.2.1 Aldurazyme
21.2.2 Cerezyme
21.2.3 Fabrazyme
21.2.4 Myozyme/Lumizyme
21.2.5 Lantus
21.3 Amgen
21.3.1 Enbrel
21.3.2 Neulasta
21.3.3 Xgeva/Prolia
21.4 Novo Nordisk
21.4.1 NovoRapid/NovoLog
21.4.2 Victoza
21.5 Other Prominent and Future Vendors
22. Key Vendor Analysis
22.1 Amgen
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Product Segmentation by Revenue 2013
22.1.4 Sales by Geographical Segmentation 2013
22.1.5 Business Strategy
22.1.6 Key Information
22.1.7 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Geographical Segmentation by Revenue
22.2.6 Business Strategy
22.2.7 Key Information
22.2.8 SWOT Analysis
22.3 Novo Nordisk A/S
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Strategy
22.3.5 Revenue Segmentation by Business
22.3.6 Revenue Comparison by Business Segments 2012 and 2013
22.3.7 Sales by Geography
22.3.8 Key Information
22.3.9 SWOT Analysis
22.4 Sanofi
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Geographical Segmentation by Revenue 2013
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
23. Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Biologic Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Global Biologic Therapeutics Market Segmentation by Molecule Type
Exhibit 4: Global Biologic Therapeutics Market by Molecule Type 2013
Exhibit 5: Global Biologic Therapeutics Market by Molecule Type 2018
Exhibit 6: Global Biologic Therapeutics Market by Molecule Type 2013-2018 (US$ billion)
Exhibit 7: Global Biologic Therapeutics Market by Molecule Type 2013-2018
Exhibit 8: Global Biologic Therapeutics Market Segments 2013-2018
Exhibit 9: YoY Growth Rate of Global Biologic Therapeutics Market Segments 2013-2018
Exhibit 10: Global Biologic Therapeutics Market Segmentation by Geography 2013
Exhibit 11: Key Factors Influencing the Global Protein Therapeutics Market
Exhibit 12: Global Protein Therapeutics Market Key Trends
Exhibit 13: Global Protein Therapeutics Market 2013-2018 (US$ billion)
Exhibit 14: Global Protein Therapeutics Market by Molecule Type
Exhibit 15: Global Protein Therapeutics Market by Molecule Type 2013
Exhibit 16: Global Protein Therapeutics Market by Molecule Type 2018
Exhibit 17: Global Protein Therapeutics Market by Molecule Type 2013-2018 (US$ billion)
Exhibit 18: Global Protein Therapeutics Market by Molecule Type 2013-2018
Exhibit 19: Global Protein Therapeutics Market Segmentation 2013-2018
Exhibit 20: YoY Growth Rate of Global Protein Therapeutics Market Segments 2013-2018
Exhibit 21: Global Monoclonal Antibodies Market 2013-2018 (US$ billion)
Exhibit 22: Global Enzymes Market 2013-2018 (US$ billion)
Exhibit 23: Global Other Protein Therapeutics Market 2013-2018 (US$ billion)
Exhibit 24: Global Vaccines Market Drivers
Exhibit 25: Global Vaccines Market Challenges
Exhibit 26: Global Vaccines Market Trends
Exhibit 27: Global Vaccines Market 2013-2018 (US$ billion)
Exhibit 28: Global Vaccines Market Segmentation by Vaccine Type
Exhibit 29: Global Vaccines Market Segmentation by End-user Age Group
Exhibit 30: Global Vaccines Market Segmentation by End-user Age Group 2013
Exhibit 31: Global Vaccines Market Segmentation by End-user Age Group 2018
Exhibit 32: Global Vaccines Market Segmentation by End-user Age Group 2013-2018 (US$ billion)
Exhibit 33: Global Vaccines Market Segmentation by End-user Age Group 2013-2018
Exhibit 34: Global Vaccines Market Segmentation 2013-2018
Exhibit 35: YoY Growth Rate of Global Vaccines Market Segments 2013-2018
Exhibit 36: Global Pediatric Vaccines Market 2013-2018 (US$ billion)
Exhibit 37: Global Adult Vaccines Market 2013-2018 (US$ billion)
Exhibit 38: Key Factors Influencing the Global Cell Therapy Market
Exhibit 39: Global Cell Therapy Market 2013-2018 (US$ billion)
Exhibit 40: Global Biologic Therapeutics Market Drivers
Exhibit 41: Global Biologic Therapeutics Overall Market Drivers
Exhibit 42: World’s Population Aged 60 and Above 2010-2020 (billion)
Exhibit 43: Global Biologic Therapeutics Segment Specific Drivers
Exhibit 44: Incidence and Prevalence of Type 1 Diabetes in Children (0-14 Years) 2013 (in thousands)
Exhibit 45: Global Biologic Therapeutics Market Challenges
Exhibit 46: Global Biologic Therapeutics Overall Market Challenges
Exhibit 47: Global Biologic Therapeutics Segment Specific Challenges
Exhibit 48: Global Biologic Therapeutics Market Trends
Exhibit 49: Global Biologic Therapeutics Market General Trends
Exhibit 50: Global Biologic Therapeutics Segment Specific Trends
Exhibit 51: Market Statistics for Key Vendors in Global Biologic Therapeutics Market
Exhibit 52: Global Biologic Therapeutics Market Share Analysis 2013
Exhibit 53: Global Biologic Therapeutics Market Share Analysis 2018
Exhibit 54: Global Biologic Therapeutics Market Share Analysis of Key Vendors 2013
Exhibit 55: Global Biologic Therapeutics Market Share Analysis of Key Vendors 2018
Exhibit 56: YoY Growth Rate of Key Vendors in the Global Biologic Therapeutics Market
Exhibit 57: F. Hoffmann-La Roche Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 58: Sanofi Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 59: Amgen Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 60: Novo Nordisk Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 61: Revenue of Major Biologic Therapeutics of Key Vendors
Exhibit 62: F. Hoffmann-La Roche: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 63: Geography-wise Segmentation of Avastin 2013 (US$ million)
Exhibit 64: Geography-wise Segmentation of Avastin 2013
Exhibit 65: Avastin Market Size and Forecast 2013-2018 (US$ million)
Exhibit 66: Geography-wise Segmentation of Herceptin 2013 (US$ million)
Exhibit 67: Geography-wise Segmentation of Herceptin 2013
Exhibit 68: Herceptin Market Size and Forecast 2013-2018 (US$ million)
Exhibit 69: Geography-wise Segmentation of Kadcyla 2013 (US$ million)
Exhibit 70: Geography-wise Segmentation of Kadcyla 2013
Exhibit 71: Kadcyla Market Size and Forecast 2013-2018 (US$ million)
Exhibit 72: Timeline of Key Regulatory Approvals of Lucentis
Exhibit 73: Lucentis Sales by Geographical Segmentation 2006-2013 (US$ million)
Exhibit 74: Lucentis Revenue 2006-2013 (US$ million)
Exhibit 75: Geography-wise Segmentation of MabThera/Rituxan 2013 (US$ million)
Exhibit 76: Geography-wise Segmentation of MabThera/Rituxan 2013
Exhibit 77: MabThera/Rituxan Market Size and Forecast 2013-2018 (US$ million)
Exhibit 78: Geography-wise Segmentation of Pegasys 2013 (US$ million)
Exhibit 79: Geography-wise Segmentation of Pegasys 2013
Exhibit 80: Geography-wise Segmentation of Perjeta 2013 (US$ million)
Exhibit 81: Geography-wise Segmentation of Perjeta 2013
Exhibit 82: Perjeta Market Size and Forecast 2013-2018 (US$ million)
Exhibit 83: SanofI: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 84: Geography-wise Segmentation of Aldurazyme 2013 (US$ million)
Exhibit 85: Geography-wise Segmentation of Aldurazyme 2013
Exhibit 86: Geography-wise Segmentation of Cerezyme 2013 (US$ million)
Exhibit 87: Geography-wise Segmentation of Cerezyme 2013
Exhibit 88: Geography-wise Segmentation of Fabrazyme 2013 (US$ million)
Exhibit 89: Geography-wise Segmentation of Fabrazyme 2013
Exhibit 90: Geography-wise Segmentation of Myozyme/Lumizyme 2013 (US$ million)
Exhibit 91: Geography-wise Segmentation of Myozyme/Lumizyme 2013
Exhibit 92: Geography-wise Segmentation of Lantus 2013 (US$ million)
Exhibit 93: Geography-wise Segmentation of Lantus 2013
Exhibit 94: Lantus Market Size and Forecast 2013-2018 (US$ million)
Exhibit 95: Geography-wise Segmentation of Enbrel 2013 (US$ million)
Exhibit 96: Geography-wise Segmentation of Enbrel 2013
Exhibit 97: Enbrel Market Size and Forecast 2013-2018 (US$ million)
Exhibit 98: Geography-wise Segmentation of Neulasta 2013 (US$ million)
Exhibit 99: Geography-wise Segmentation of Neulasta 2013
Exhibit 100: Neulasta Market Size and Forecast 2013-2018 (US$ million)
Exhibit 101: Geography-wise Segmentation of Xgeva/Prolia 2013 (US$ million)
Exhibit 102: Geography-wise Segmentation of Xgeva/Prolia 2013
Exhibit 103: Xgeva/Prolia Market Size and Forecast 2013-2018 (US$ million)
Exhibit 104: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 105: Geography-wise Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 106: Geography-wise Segmentation of NovoRapid/NovoLog 2013 (US$ million)
Exhibit 107: Geography-wise Segmentation of NovoRapid/NovoLog 2013
Exhibit 108: NovoRapid/NovoLog Market Size and Forecast 2013-2018 (US$ million)
Exhibit 109: Geography-wise Segmentation of Victoza 2013 (US$ million)
Exhibit 110: Geography-wise Segmentation of Victoza 2013
Exhibit 111: Victoza Market Size and Forecast 2013-2018 (US$ million)
Exhibit 112: Amgen: Product Segmentation by Revenue 2013
Exhibit 113: Amgen: Sales by Geographical Segmentation 2013
Exhibit 114: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 115: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 116: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 117: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 118: Business Segments of Novo Nordisk A/S 2013
Exhibit 119: Novo Nordisk A/S: Business Segmentation 2013
Exhibit 120: Novo Nordisk A/S: Revenue Comparison 2012 and 2013 (US$ million)
Exhibit 121: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 122: Sanofi: Business Segmentation by Revenue 2013
Exhibit 123: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 124: Sanofi: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：生物学的製剤の世界市場：タンパク質治療薬、ワクチン、細胞治療薬■ 英文：Global Biologic Therapeutics Market 2014-2018
■ 発行日：2014年10月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4486
■ 調査対象地域：グローバル
- 分散アンテナシステム（DAS）の世界市場2016-2020About Distributed Antenna Systems DAS or distributed antenna systems are components that are used to boost cellular network coverage to deal with dead spots or isolated spots of poor coverage. These isolated or dead spots are mostly in large buildings, especially in closed locations, where the cellular network is the weakest. DAS are installed as a network of a large number of small antennas insta …
- エレクトロクロミック・ガラス及びフィルムの世界市場2016-2023Electrochromic (EC) glass has built up an established niche market for automotive mirrors, but n-tech Research's latest analysis underscores the attractive revenue opportunities for EC glass in smart windows in both architecture and transportation. Customers are becoming more receptive to messaging beyond energy efficiency, into more holistic cost comparisons tied to alternative glass systems with …
- 保険詐欺検知の世界市場予測（～2024年）The exponential rise in the sophistication of cyber attacks insurance sector and substantial monetary losses due to these attacks will drive the overall insurance fraud detection market The global insurance fraud detection market size is expected to grow from USD 2.5 billion in 2019 to USD 7.9 billion by 2024, at a compound annual growth rate (CAGR) of 25.8% during the forecast period. Various fac …
- 世界の静電容量センサー市場Capacitive sensors are considered to be far better as compared to the resistive sensing technology due to high accuracy, sensitivity, and absence of wear & tear problem. They are continuously replacing the resistive sensors in most of the applications because of various advantages. Some of the major advantages are shown in the figure below. All the applications, industry verticals, and their sub s …
- スポーツ釣り用品の世界市場：釣り用リール、釣り用ルアー、その他About Sports Fishing Sports fishing, also known as recreational fishing, is fishing for pleasure or competition. Sports fishing is mainly done with a rod, reel, line, hooks, and a range of baits or lures. The practice of catching fish with a hook is called angling, hence, people who engage in sports fishing are also known as anglers. Technavio’s analysts forecast the global sports fishing equipmen …
- 空気式ネブライザーの世界市場2016-2020About the Pneumatic Nebulizers Market Nebulizers are drug delivery devices that use oxygen, compressed air, or ultrasonic energy to convert drug suspensions or solutions into aerosols or mist. Drugs in the form of aerosols or mist are easier for the user to inhale and the lungs to absorb. This drug delivery method helps administer different drugs, such as bronchodilators, antibiotics, antifungals, …
- セラミックタイルの世界市場：製品別（床タイル、壁タイル、他のセラミックタイル）、用途別（住宅用交換品、商業用、新築）、分析とセグメント予測、－2020Global Ceramic Tiles Market is expected to reach USD 125.32 billion by 2020, according to a new study by Grand View Research, Inc. Construction industry growth in BRICS coupled with rising demand for new residential structures in emerging markets of China and India due to urbanization is expected to drive market demand for ceramic tiles over the forecast period. Stringent environment regulations p …
- 石こうボードの世界市場動向分析：製品別（ウォールボード、天井ボード、プリコートボード）、用途別（住宅、企業、商業、機関）、セグメント予測The global gypsum board market is expected to reach USD 54.12 billion by 2022, according to a new report by Grand View Research, Inc. Increasing residential and commercial construction spending in Asia Pacific and Middle East is anticipated to drive global gypsum board market growth over the next seven years. Developed regions such as North America and Europe are expected to witness significant gr …
- 世界の軍用機MRO市場：地域別分析Summary This report offers detailed analysis of the global Global Military Aviation MRO market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Global Military Aviation MRO market. Key Findings "The Global Military Aviation MRO Market 2015-2025 - Country Analysis: Market Profile" provides detai …
- 胃部・食道胃接合部腺癌市場：中国の治療薬市場Gastric and Gastroesophageal Junction Adenocarcinoma - China Drug Forecast and Market Analysis to 2024 Summary Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) represents the majority of gastric cancer cases worldwide. It is the fifth most diagnosed cancer globally, and the third most common cause of cancer death in the world. The major treatments for G/GEJAC are chemotherapy-based, …
- 有機過酸化物の世界市場予測（～2022年）：ジアシル、ケトン、過炭酸塩、ジアルキル、ヒドロペルオキシド、パーオキシケタール、ペルオキシエステル“Organic peroxide market to grow at a CAGR of 3.4% (2017-2022)”The global organic peroxide market is estimated at USD 902.4 million in 2017 and is projected to reach USD 1,069.1 million by 2022, at a CAGR of 3.4% between 2017 and 2022. The increased demand for organic peroxide in different applications, such as chemicals & plastics, coatings, adhesives & elastomers, paper & textile, detergents, an …
- 世界の家庭用品（Homewares）市場動向（2014-2018）TechNavio's analysts forecast the Global Homewares market to grow at a CAGR of 4.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in household disposable income. The Global Homewares market has also been witnessing increasing demand from emerging economies. However, the low brand loyalty could pose a challenge to the growth of this mar …
- 超低温フリーザーの世界市場2017-2021ABSTRACTAbout Ultra-Low Temperature Freezer The global ULT freezers market is growing moderately at a rate of 3.08%, which can be attributed to increased investments in R&D. Also, the market is driven by the expansion of end-user segments such as biobanks, hospitals and diagnostic centers, and others that use cold storage solutions such as ULT freezers to store a broad range of specimens and produ …
- Tarceva (Non-Small Cell Lung Cancer)：市場予測と分析（～2022）Tarceva (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment land …
- Kazakhstanの硫酸バリウム市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Kazakhstan and its perspectives on the global market for Natural barium sulphate (barytes). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Natural barium sulphate (barytes) export/import operations in Kazakhst …
